1. Home
  2. GNFT vs CURR Comparison

GNFT vs CURR Comparison

Compare GNFT & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • CURR
  • Stock Information
  • Founded
  • GNFT 1999
  • CURR 2013
  • Country
  • GNFT France
  • CURR Singapore
  • Employees
  • GNFT N/A
  • CURR N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • CURR Business Services
  • Sector
  • GNFT Health Care
  • CURR Consumer Discretionary
  • Exchange
  • GNFT Nasdaq
  • CURR Nasdaq
  • Market Cap
  • GNFT 216.7M
  • CURR 224.4M
  • IPO Year
  • GNFT 2019
  • CURR N/A
  • Fundamental
  • Price
  • GNFT $4.24
  • CURR $3.01
  • Analyst Decision
  • GNFT Strong Buy
  • CURR Strong Buy
  • Analyst Count
  • GNFT 2
  • CURR 1
  • Target Price
  • GNFT $10.00
  • CURR $3.50
  • AVG Volume (30 Days)
  • GNFT 9.4K
  • CURR 2.2M
  • Earning Date
  • GNFT 09-22-2025
  • CURR 11-01-2025
  • Dividend Yield
  • GNFT N/A
  • CURR N/A
  • EPS Growth
  • GNFT N/A
  • CURR N/A
  • EPS
  • GNFT N/A
  • CURR N/A
  • Revenue
  • GNFT $52,994,715.00
  • CURR $40,227,053.00
  • Revenue This Year
  • GNFT $3.14
  • CURR N/A
  • Revenue Next Year
  • GNFT N/A
  • CURR $14.56
  • P/E Ratio
  • GNFT N/A
  • CURR N/A
  • Revenue Growth
  • GNFT N/A
  • CURR N/A
  • 52 Week Low
  • GNFT $2.55
  • CURR $0.33
  • 52 Week High
  • GNFT $4.79
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 54.62
  • CURR 57.46
  • Support Level
  • GNFT $4.10
  • CURR $3.05
  • Resistance Level
  • GNFT $4.38
  • CURR $3.88
  • Average True Range (ATR)
  • GNFT 0.19
  • CURR 0.69
  • MACD
  • GNFT 0.02
  • CURR 0.03
  • Stochastic Oscillator
  • GNFT 82.31
  • CURR 44.31

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: